EVAX Company Profile and Key Details
Evaxion Biotech A/S
EVAX Stock Price Chart
Stock Price Today
Evaxion Biotech A/S (EVAX) stock surged +32.50%, trading at $3.18 on NASDAQ, up from the previous close of $2.40. The stock opened at $3.88, fluctuating between $2.93 and $4.05 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Evaxion Biotech A/S, a clinical-stage biotech company, engages in developing artificial intelligence-powered immunotherapies for cancers, bacterial diseases, and viral infections. The company develops EVX-01, a cancer immunotherapy that is in clinical Phase IIb trial for metastatic melanoma; EVX-02, a DNA-based cancer immunotherapy that is in Phase IIa trial for adjuvant melanoma; and EVX-03, a DNA-based immunotherapy for the treatment of various cancers. Its programs also include EVX-B1, EVX-B2, and EVX-V1, which are vaccines that are in pre-clinical stage for the treatment of bacterial and viral diseases. The company was incorporated in 2008 and is headquartered in Hørsholm, Denmark.
Company Information
| Employees | 49 |
| Beta | -0.23 |
| Sales or Revenue | $73.11K |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Evaxion Biotech A/S (NASDAQ: EVAX) stock price is $3.18 in the last trading session. During the trading session, EVAX stock reached the peak price of $4.05 while $2.93 was the lowest point it dropped to. The percentage change in EVAX stock occurred in the recent session was 32.5% while the dollar amount for the price change in EVAX stock was $0.78.
The NASDAQ listed EVAX is part of Biotechnology industry that operates in the broader Healthcare sector. Evaxion Biotech A/S designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Bo Lokke Karmark
Chief Financial Officer
Dr. Birgitte Rono Ph.D.
Chief Scientific Officer
Mr. Jesper Nyegaard Nissen
Chief Operating Officer
Dr. Erik Deichmann Heegaard DMSC, M.D., Ph.D.
Chief Medical Officer
Dr. Jürgen Langhärig EMBA, Ph.D.
Head of Bus. Devel. & Member of Advisory Board
Mr. Andreas Holm Mattsson
Co-Founder and Chief AI & Culture Officer
Dr. Per Goran Oskar Norlen
Chief Executive Officer
Dr. Per Norlen
Chief Executive Officer
Dr. Niels Iversen Moeller M.D.
Co-Founder, Vice President of Bus. & Director
EVAX's closing price is 8.11% higher than its 52-week low of $2.22 where as its distance from 52-week high of $23.70 is -89.87%.
Number of EVAX employees currently stands at 49.
Official Website of EVAX is: https://www.evaxion-biotech.com
EVAX could be contacted at phone 455 353 1850 and can also be accessed through its website. EVAX operates from Dr. Neergaards Vej, Horsholm, 2970, Denmark.
EVAX stock volume for the day was 61.78M shares. The average number of EVAX shares traded daily for last 3 months was 1.26M.
The market value of EVAX currently stands at $996.38K with its latest stock price at $3.18 and 6.27M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com